Drug-eluting stents in acute myocardial infarction of.docVIP

 PAGE \* MERGEFORMAT 22 Drug-eluting stents in acute myocardial infarction of [Abstract] drug-eluting stent (drug eluting stent, DES) appear in the history of coronary revascularization milestone, the current treatment of coronary intervention (percutaneous coronary intervention, PCI) has been in the DES era. A large number of studies DES in stable coronary artery disease demonstrate the application, can reduce the restenosis rate, and strong security. Although the reason to believe that DES in acute myocardial infarction (acute myocardial infarction, AMI) Patients can obtain the stability of the crown similar efficacy in patients with heart disease, but patients with stable coronary heart disease compared to, AMI patients, especially patients with STEMI have a stronger thrombus load, DES evidence-based medical evidence used in AMI is not yet sufficient. In recent years, from non- randomized retrospective study, the single-center randomized controlled study, to the multi-center prospective randomized controlled studies have shown that emergency PCI in the DES in AMI safe and effective. At the same time a number of studies have confirmed that DES in elderly patients, diabetic patients and small vessel disease of the AMI in the same safe and effective. domestically DES emergency PCI in AMI safety and effectiveness of the application has been initially confirmed. However, DES’s security, in particular, the late and very late thrombosis and other issues still need longer follow-up large-scale multi-center prospective randomized controlled study further confirmed. uncoated and coated biodegradable and progenitor cell capture stent DES there is hope to overcome the shortcomings of the widely used DES or potential hazards. [Keywords:] drug-eluting stent; acute myocardial infarction; Application For acute myocardial infarction (acute myocardial infarction, AMI) patients, both ST-segment elevation myocardial infarction (ST-segment elevation myocardial infarctio